D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 59 500 KRW -0.83% Market Closed
Market Cap: 534.5B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note

Dong-A ST Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dong-A ST Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
D
Dong-A ST Co Ltd
KRX:170900
Accounts Receivables
â‚©110B
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
2%
Yuhan Corp
KRX:000100
Accounts Receivables
â‚©667.9B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
13%
SK Biopharmaceuticals Co Ltd
KRX:326030
Accounts Receivables
â‚©111.4B
CAGR 3-Years
123%
CAGR 5-Years
294%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Accounts Receivables
â‚©212.3B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Accounts Receivables
â‚©34.2B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
3%
C
Celltrion Pharm Inc
KOSDAQ:068760
Accounts Receivables
â‚©196.8B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
18%
No Stocks Found

Dong-A ST Co Ltd
Glance View

Market Cap
511.6B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
96 510.53 KRW
Undervaluation 38%
Intrinsic Value
Price
D

See Also

What is Dong-A ST Co Ltd's Accounts Receivables?
Accounts Receivables
110B KRW

Based on the financial report for Sep 30, 2024, Dong-A ST Co Ltd's Accounts Receivables amounts to 110B KRW.

What is Dong-A ST Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
2%

Over the last year, the Accounts Receivables growth was 6%. The average annual Accounts Receivables growth rates for Dong-A ST Co Ltd have been 8% over the past three years , 2% over the past five years , and 2% over the past ten years .

Back to Top